Lonza Names Paula McGeechan Head of Hygiene and Preservation Technology


Alternativ







Blackley (UK) - 13 June 2018
Lonza has named Paula McGeechan Global Head of Hygiene and Preservation Technology for the Consumer Product Ingredients business unit. In her new role, she coordinates and aligns Lonza’s hygiene and preservation research, development and technical service; works to enhance the company’s application and formulation skills to provide customers with integrated solutions; and drives innovation to build industry expertise and enhance Lonza’s functional ingredient offerings.



In her 29 years of experience with Lonza and its predecessor companies, McGeechan has held various positions in R&D and technical service, with technical responsibility for biocides research, formulation development and customer service.

McGeechan has several patents issued relating to antimicrobials and biocides in applications ranging from metalworking fluids to preservatives. She earned a B.Sc. degree in Biochemistry from the University of Manchester (UK).


About Lonza Consumer Product Ingredients - Hygiene
A key part of Lonza’s Consumer Product Ingredients business unit, the Hygiene business offers a broad portfolio of registered actives, preservatives and formulations for use in disinfectants, and institutional and household cleaning products. This wide range of solutions is used to disinfect and sanitize food processing plants, restaurants, grocery stores, hospitals, homes and more. More information can be found at www.lonzabiocides.com

About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment.

Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.

Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fastmoving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.

Founded in 1897 in the Swiss Alps, Lonza today is a wellrespected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com.

« back